In a 4‑year‑old child, where and how should the DTaP (diphtheria, tetanus, acellular pertussis) vaccine be administered intramuscularly?

DTaP Injection Site for 4-Year-Old Children

For a 4-year-old child receiving DTaP vaccine, administer 0.5 mL intramuscularly into the deltoid muscle of the upper arm. 1, 2, 3

Dosage and Route

• The standard dose is 0.5 mL administered intramuscularly—fractional doses should never be given 1
• At age 4 years, this represents the fifth (second booster) dose in the routine DTaP series 1

Preferred Injection Site by Age

The injection site changes based on the child's age:

• Children ≥3 years old: The deltoid muscle is the preferred site 1, 2, 3
• Children through age 2 years: The anterolateral aspect of the thigh is preferred 1, 3, 4

Since your patient is 4 years old, the deltoid muscle is the appropriate site 1, 2, 3. This recommendation comes from the most recent 2018 ACIP guidelines, which explicitly state that for children aged ≥3 years, the deltoid muscle is preferred 1.

Clinical Rationale

The age-based site selection reflects muscle development:

• In younger infants and toddlers, the anterolateral thigh provides the largest muscle mass and is therefore preferred 4
• By age 3 years and beyond, the deltoid muscle is usually large enough for safe intramuscular injection 1, 4

Evidence on Site Selection

Research supports the deltoid as preferable in older children:

• A 1989 study found that deltoid injection at 18 months resulted in significantly less severe pain (8.1% vs 30.5%), less limping, and fewer movement restrictions compared to thigh injection, though slightly more redness and swelling occurred 5
• Parents rated reactions as moderate-to-severe less often with deltoid injection (37.9% vs 64.2%) 5

Administration Technique

• Use a 90-degree angle for intramuscular injection 6
• Needle length should be 7/8 to 1¼ inches (22-25 gauge) for children, based on muscle size 6
• Do not inject into the gluteal area or near major nerve trunks 4
• Aspiration before injection is not required 6

Important Safety Considerations

• Observe for syncope: Monitor the child for 15 minutes post-vaccination, as syncope is reported following DTaP administration, especially in this age group 1, 3, 6
• Have epinephrine 1:1000 immediately available for potential anaphylactic reactions 4
• If administering multiple vaccines simultaneously, use separate syringes at different anatomic sites, separated by at least 1 inch 1, 3